Skip to main content
SpringerLink
Log in

Duration of Caffeine for Apnea of Prematurity—A Randomized Controlled Trial

  • Original Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objectives

There is sufficient evidence to support use of caffeine therapy for apnea of prematurity, but practices vary widely when it comes to discontinuing therapy. This study was planned to compare ‘recurrence of apnea of prematurity’ (RAP); when 2 protocols were used to stop caffeine therapy.

Methods

Neonates delivered at 26–32 wk gestation on caffeine therapy for apnea of prematurity were randomized into 2 groups: Group 1—caffeine stopped at 7 d apnea-free period, and Group 2—continued for a prefixed period till at least 34 wk postmenstrual age (PMA). Proportion of infants in each group with RAP were analyzed.

Results

Each group consisted of 60 infants. Proportion of infants in each group with RAP, were not different (15% vs 13%); odds ratio (OR) 0.87; 95% confidence interval (CI) (0.31–2.43). Caffeine could be stopped earlier (33 vs 34 wk PMA); and cumulative duration of therapy was lesser (19.5 vs 33 d) when stopped at 7 d apnea-free period. Other studied outcomes were similar between the two groups.

Conclusions

Mandatorily continuing caffeine therapy up to 34 wk PMA in select preterm groups does not seem to decrease risk of recurrence of apnea. Larger trials that specifically study extremely preterm infants are required to make robust recommendations on when to stop therapy.

Clinical Trials Registry of India no

CTRI/2016/12/007559. http://ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=14195&EncHid=&modid=&compid=%27,%2714195det%27

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–21.

    Article  CAS  Google Scholar 

  2. Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK, Smith PB; On behalf of the Best Pharmaceuticals for Children Act- Pediatrics trials network. Medication use in the neonatal intensive care unit. Am J Perinatol. 2014;31(9):811–22.

  3. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–902.

    Article  CAS  Google Scholar 

  4. Lodha A, Seshia M, McMillan DD, et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 2015;169:33–8.

    Article  Google Scholar 

  5. Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics. 1997;100:795–801.

    Article  Google Scholar 

  6. Picone S, Bedetta M, Paolillo P. Caffeine citrate: when and for how long. A literature review. J Matern Fetal Neonatal Med. 2012;25:11–4.

    Article  CAS  Google Scholar 

  7. Al Ansari E, Qeretli R, Fayed M, Altammami H. Caffeine therapy practice in the management of apnea of prematurity: national survey in Saudi Arabia. J Clin Neonatol. 2018;7:217–23.

    Article  Google Scholar 

  8. Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exerceise? Pediatrics. 2007;119:936–40.

    Article  Google Scholar 

  9. Atik A, Harding R, De Matteo R, et al. Caffeine for apnea of prematurity: effects on the developing brain. Neurotoxicol. 2016;58:94–102.

  10. Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001;107(4):660–3.

    Article  CAS  Google Scholar 

  11. Rhein LM, Dobson NR, Darnall RA, et al. Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized controlled trial. JAMA Pediatr. 2014;168:250–7.

    Article  Google Scholar 

  12. Lin Z, Green RS, Chen S, et al. Quantification of EUGR as a measure of the quality of nutritional care of premature infants. PLoS One. 2015;10(7):e0132584.

    Article  Google Scholar 

  13. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin N Am. 1986;33(1):179–201.

    Article  CAS  Google Scholar 

  14. Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116(6):1353–60.

    Article  Google Scholar 

  15. Early treatment for Retinopathy of Prematurity Cooperative Group. Revised indication for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–94.

    Article  Google Scholar 

  16. Lorch SA, Srinivasan L, Escobar GJ. Epidemiology of apnea and bradycardia resolution in premature infants. Pediatrics. 2011;128(2):e366–73.

    Article  Google Scholar 

  17. Prakash R, Pournami F, Prabhakar J, et al. G573(P) ‘How long is not short?’: Duration of caffeine therapy in preterm infants- a randomized controlled trial. Arch Dis Child. 2020;105:A205–6.

    Google Scholar 

  18. Aranda JV, Gorman W, Bergsteinsson H, Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr. 1977;90(3):467–72.

    Article  CAS  Google Scholar 

  19. Abdel-Hady A, Nasef N, Shabaan AE, Nour I. Caffeine therapy in preterm infants. World J Clin Pediatr. 2015;4(4):81–93.

    Article  Google Scholar 

  20. Eichenwald EC, Committee on fetus and newborn, American Academy of Pediatrics. Apnea of prematurity. Pediatrics. 2016;137(1):e20153757.

  21. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100(3):354–9.

    Article  CAS  Google Scholar 

  22. Martin RJ, Wang K, Köroğlu O, Di Fiore J, Kc P. Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology. 2011;100(3):303–10.

    Article  CAS  Google Scholar 

  23. Poets CF, Roberts RS, Schmidt B, et al. Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. JAMA. 2015;314(6):595–603.

    Article  CAS  Google Scholar 

  24. Butler TJ, Firestone KS, Grow JL, Kantak AD. Standardizing documentation and the clinical approach to apnea of prematurity reduces length of stay, improves staff satisfaction, and decreases hospital cost. Jt Comm J Qual Patient Saf. 2014;40(6):263–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neonatology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, 695029, India

    Raj Prakash, Femitha Pournami, Jyothi Prabhakar, Anand Nandakumar, P. M. C. Nair & Naveen Jain

Authors
  1. Raj Prakash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Femitha Pournami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jyothi Prabhakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anand Nandakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. M. C. Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naveen Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NJ conceived the study; NJ, JP, PMCN planned and designed the study protocol; RP (principle investigator) collected data; RP, NJ, AN and FP contributed to statistical analysis and interpretation; RP, FP drafted the manuscript. All authors approved the final manuscript. NJ will act as guarantor for this paper.

Corresponding author

Correspondence to Femitha Pournami.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 68 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prakash, R., Pournami, F., Prabhakar, J. et al. Duration of Caffeine for Apnea of Prematurity—A Randomized Controlled Trial. Indian J Pediatr 88, 1174–1179 (2021). https://doi.org/10.1007/s12098-021-03659-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-021-03659-y

Keywords

Search

Navigation